Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.1K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.0K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vertebral computed tomography attenuation to case-find low bone density in people undergoing lung cancer screening.

The British journal of radiology·2026
Same author

Interventions for smoking cessation in people undergoing lung cancer screening.

The Cochrane database of systematic reviews·2026
Same author

Authors' Response to the Letter by Sun et al.

Health expectations : an international journal of public participation in health care and health policy·2026
Same author

Neutrophil-related gene expression profile is associated with future paediatric bronchiectasis exacerbations.

Journal of molecular medicine (Berlin, Germany)·2026
Same author

Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature.

Cell reports. Medicine·2026
Same author

Acute effects of low-dose bisoprolol on lung function and blood pressure in COPD patients.

ERJ open research·2026

Related Experiment Video

Updated: Jan 3, 2026

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

11.3K

Extracellular vesicles in chronic obstructive pulmonary disease (COPD).

Hannah E O'Farrell1, Ian A Yang1,2

  • 1UQ Thoracic Research Centre, Faculty of Medicine, The University of Queensland, Brisbane, Australia.

Journal of Thoracic Disease
|November 19, 2019
PubMed
Summary

Extracellular vesicles (EVs) show promise as biomarkers for diagnosing chronic obstructive pulmonary disease (COPD) and its exacerbations. Bioengineered EVs may also offer new therapeutic strategies for COPD management.

Keywords:
Extracellular vesicles (EVs)biomarkerschronic obstructive pulmonary disease (COPD)therapeutics

More Related Videos

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
06:39

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity

Published on: September 1, 2023

3.8K
Isolation of Extracellular Vesicles from Murine Bronchoalveolar Lavage Fluid Using an Ultrafiltration Centrifugation Technique
09:18

Isolation of Extracellular Vesicles from Murine Bronchoalveolar Lavage Fluid Using an Ultrafiltration Centrifugation Technique

Published on: November 9, 2018

10.0K

Related Experiment Videos

Last Updated: Jan 3, 2026

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury
08:27

Bronchoalveolar Lavage Exosomes in Lipopolysaccharide-induced Septic Lung Injury

Published on: May 21, 2018

11.3K
Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity
06:39

Author Spotlight: Accelerating Research on Bacterial Extracellular Vesicles Separation and Heterogeneity

Published on: September 1, 2023

3.8K
Isolation of Extracellular Vesicles from Murine Bronchoalveolar Lavage Fluid Using an Ultrafiltration Centrifugation Technique
09:18

Isolation of Extracellular Vesicles from Murine Bronchoalveolar Lavage Fluid Using an Ultrafiltration Centrifugation Technique

Published on: November 9, 2018

10.0K

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Biomarker Discovery

Background:

  • Chronic obstructive pulmonary disease (COPD) is a major global health issue characterized by inflammation and irreversible airflow obstruction.
  • Extracellular vesicles (EVs), released by cells into bodily fluids, mediate cell-cell communication via their bioactive cargo.
  • EVs are implicated in various physiological and pathological processes.

Purpose of the Study:

  • To review the potential of EVs as diagnostic and therapeutic biomarkers in COPD management.
  • To explore the role of EVs in the pathogenesis of COPD.
  • To highlight recent advances in EV-based diagnostics and therapeutics for COPD.

Main Methods:

  • Literature review of recent studies on extracellular vesicles and COPD.
  • Analysis of evidence for EVs in COPD diagnosis, phenotyping, and progression.
  • Examination of therapeutic applications of engineered EVs for lung diseases.

Main Results:

  • EVs show potential in distinguishing COPD exacerbations from stable states and characterizing COPD phenotypes.
  • EVs are linked to inflammatory mediators driving COPD progression.
  • Bacterial EVs and their cargo impact the lung microenvironment.
  • Engineered EVs are emerging as drug delivery vehicles for lung diseases.

Conclusions:

  • EVs represent promising biomarkers for COPD diagnosis and monitoring.
  • EVs play a significant role in COPD pathogenesis.
  • Bioengineered EVs offer potential novel therapeutic strategies for COPD.